What HPLC Testing Means for Research Peptides

What HPLC Testing Actually Measures

HPLC is a chromatographic separation technique used to identify, quantify, and assess the purity of chemical compounds in a mixture. For synthetic research peptides, it separates the target compound from impurities — including truncated sequences, deletion sequences, oxidized variants, and residual synthesis reagents — based on differences in polarity and how each component interacts with the chromatography column.

The output of an HPLC run is a chromatogram: a graph plotting detector signal (typically UV absorbance at 220 nm for peptides) against time. Each peak in the chromatogram represents a distinct chemical species. The area under each peak is proportional to the quantity of that species in the sample. Purity is expressed as the percentage of the total peak area represented by the target compound's peak.

What HPLC measures is chromatographic purity — not biological activity, safety, or suitability for any specific use. A peptide with 99% HPLC purity contains 99% of the target compound by area under the chromatographic curve. It says nothing about the compound's application or fitness for non-research contexts.

How Reverse-Phase HPLC Works for Peptides

Peptide purity analysis almost universally uses reverse-phase HPLC (RP-HPLC). In this configuration, the stationary phase (the column packing material) is hydrophobic, and the mobile phase is an aqueous-organic solvent system — typically water with acetonitrile, often with a small percentage of trifluoroacetic acid (TFA) to improve peak shape.

Peptides are separated based on their hydrophobicity. More hydrophobic peptides interact more strongly with the stationary phase and elute later. The mobile phase is typically run as a gradient — starting with a higher proportion of water and gradually increasing the organic solvent — to progressively elute compounds from least to most hydrophobic.

The detector most commonly used for peptide HPLC is a UV detector set at 220 nm. At this wavelength, the peptide bond itself absorbs light, meaning every amino acid contributes to signal regardless of whether its side chain is UV-active. This makes 220 nm detection broadly applicable across peptide sequences.

Understanding this methodology helps researchers interpret what they are reading on a COA. The purity figure on a Peptides Canada COA reflects reverse-phase HPLC analysis under defined conditions. The lab testing page provides additional context on testing methodology.

Reading Purity Percentages on a COA

When a COA states that a peptide has 98.5% purity by HPLC, it means that 98.5% of the UV-absorbing area in the chromatogram was attributed to the main peak — the target peptide. The remaining 1.5% consists of minor peaks representing impurities of various kinds.

Research-grade peptides are generally expected to meet a minimum purity threshold. Common industry standards for research applications include:

• 95%+ purity — generally acceptable for most in vitro laboratory research applications
• 98%+ purity — a higher standard often preferred for applications requiring tighter quality control
• 99%+ purity — the highest grade, typically used in highly sensitive analytical or structural biology contexts

Peptides Canada products are documented with their batch-specific HPLC purity at the time of testing. Researchers should request and review the COA for each batch, not just an average or representative figure. Batch-to-batch variation is a real consideration when working with synthetic peptides, and researchers building reproducible protocols need batch-level traceability.

If a specific purity threshold is required for your research context, the contact page is the appropriate route to discuss documentation and specification requirements before placing an order.

HPLC Alongside Mass Spectrometry

HPLC purity tells you how much of the compound is present relative to impurities, but it does not directly confirm molecular identity. That is the role of mass spectrometry (MS). In quality documentation for research peptides, HPLC and MS are complementary: HPLC establishes purity, MS confirms that the primary compound matches the expected molecular weight of the target peptide.

Mass spectrometry works by ionizing molecules and measuring their mass-to-charge ratio (m/z). For peptides, electrospray ionization (ESI-MS) is the most common technique. The resulting mass spectrum shows characteristic peaks that can be matched against the calculated molecular weight of the target sequence, confirming identity.

When a COA includes both an HPLC purity figure and a mass spectrometry confirmation, it provides two independent lines of evidence: the compound is present at high purity, and it is the correct compound. Researchers should treat COAs that include both data points as more informative than those showing only one.

Third-Party Testing and Why It Matters

HPLC and mass spectrometry data generated in-house by a supplier is useful, but the gold standard is independent third-party testing. When a peptide's purity is verified by a laboratory that has no commercial relationship with the supplier, the data carries more evidentiary weight.

Third-party testing eliminates potential conflicts of interest and validates that the supplier's internal quality control processes are producing results consistent with external analytical standards. For Canadian researchers at institutions with review boards or publication requirements, third-party COAs provide a stronger foundation for research documentation.

Researchers should ask suppliers directly whether their COA data is internally generated or produced by an independent third-party laboratory. This is one of the most important due-diligence questions in research peptide sourcing. See the FAQ for answers to common questions about the documentation Peptides Canada provides.

Supplier Transparency and Documentation Standards

A supplier who provides HPLC data is demonstrating a baseline commitment to quality transparency. However, the format, detail, and accessibility of that documentation varies considerably across the Canadian research peptide market.

When evaluating supplier documentation, researchers should look for:

• Batch-specific COAs — not generic or representative documents
• Clear identification of the testing laboratory — ideally a named third-party facility
• Chromatogram images or data — not just a purity percentage number
• Retention time and peak identification notes — supporting the analytical methodology
• Mass spectrometry data — confirming molecular identity alongside purity

Peptides Canada maintains a documentation-first approach. The lab testing and COA section of the website provides access to testing documentation for products in the research catalog. Researchers with specific documentation requirements are encouraged to contact us before ordering to confirm the format and content of available COAs.